pembrolizumab 使

Yongmei Huang1, Katherine Yoh1, Elizabeth A Szamreta2

  • 1Columbia University Vagelos College of Physicians and Surgeons, Department of Obstetrics and Gynecology, New York, NY.

概括

对复发性子宫癌的 pembrolizumab 使用正在增加,但有限. 虽然没有增加医疗保健访问,但它显著提高了治疗成本,表明需要优化治疗方法.